CERo Therapeutics Holdings, Inc. (NASDAQ: CERO) Stock Information | RedChip

CERo Therapeutics Holdings, Inc. (NASDAQ: CERO)


$0.0568
+0.0007 ( +0.89% ) 252.6K

CERo Therapeutics Holdings Inc is an innovative immunotherapy company advancing the development of next-generation engineered T-cell therapeutics for the treatment of cancer. Its proprietary approach to T cell engineering, which enables it to integrate certain desirable characteristics of both innate and adaptive immunity into a single therapeutic construct, is designed to engage the body's full immune repertoire to achieve optimized cancer therapy.

Market Data


Open


$0.0568

Previous close


$0.0561

Volume


252.6K

Market cap


$8.43M

Day range


$0.0556 - $0.0582

52 week range


$0.0467 - $12.3800

SEC Filings


Form Type Description Pages Date
4 Insider transactions 1 Dec 13, 2024
4 Insider transactions 1 Dec 10, 2024
8-k 8K-related 15 Dec 06, 2024
4 Insider transactions 1 Dec 04, 2024
4 Insider transactions 1 Dec 04, 2024
4 Insider transactions 1 Dec 04, 2024
4 Insider transactions 1 Dec 04, 2024
4 Insider transactions 1 Dec 04, 2024
4 Insider transactions 1 Dec 04, 2024
4 Insider transactions 1 Nov 20, 2024

Latest News